Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide

被引:127
作者
Bertholon, Isabelle [1 ]
Vauthier, Christine [1 ]
Labarre, Denis [1 ]
机构
[1] Fac Pharm Chatenay Malabry, CNRS, UMR 8612, Lab Physicochim Biopharm Pharmacotech, F-92296 Chatenay Malabry, France
关键词
complement activation; core-shell nanoparticles; poly(isobutylcyanoacrylate); polysaccharide; surface properties;
D O I
10.1007/s11095-006-0069-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Biodistribution of intravenously administered nanoparticles depends on opsonization. The aim of this study was the evaluation of complement activation induced by nanoparticles coated with different polysaccharides. Influences of size and configuration of dextran, dextran sulfate, or chitosan bound onto nanoparticles were investigated. Method. Core-shell nanoparticles were prepared by redox radical or anionic polymerization of isobutylcyanoacrylate in the presence of polysaccharides. Conversion of C3 into C3b in serum incubated with nanoparticles was evaluated. Results. Cleavage of C3 increased with size of dextran bound in "loops" configuration, whereas it decreased when dextran was bound in "brush." It was explained by an increasing steric repulsive effect of the brush, inducing poor accessibility to OH groups. The same trend was observed for chitosan-coated nanoparticles. Nanoparticles coated with a brush of chitosan activated the complement system lesser than nanoparticles coated with a brush of dextran. This was explained by an improved repelling effect. Dextran-sulfate-coated nanoparticles induced a low cleavage of C3 whereas it strongly enhanced protein adsorption. Conclusion. Complement activation was highly sensitive to surface features of the nanoparticles. Type of polysaccharide, configuration on the surface, and accessibility to reactive functions along chains are critical parameters for complement activation.
引用
收藏
页码:1313 / 1323
页数:11
相关论文
共 45 条
[31]   In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres [J].
Neal, JC ;
Stolnik, S ;
Schacht, E ;
Kenawy, ER ;
Garnett, MC ;
Davis, SS ;
Illum, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (10) :1242-1248
[32]   PROTEIN-REJECTING ABILITY OF SURFACE-BOUND DEXTRAN IN END-ON AND SIDE-ON CONFIGURATIONS - COMPARISON TO PEG [J].
OSTERBERG, E ;
BERGSTROM, K ;
HOLMBERG, K ;
SCHUMAN, TP ;
RIGGS, JA ;
BURNS, NL ;
VANALSTINE, JM ;
HARRIS, JM .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (06) :741-747
[33]   Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) [J].
Passirani, C ;
Barratt, G ;
Devissaguet, JP ;
Labarre, D .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1046-1050
[34]   Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system [J].
Passirani, C ;
Barratt, G ;
Devissaguet, JP ;
Labarre, D .
LIFE SCIENCES, 1998, 62 (08) :775-785
[35]   Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting [J].
Peracchia, MT ;
Fattal, E ;
Desmaële, D ;
Besnard, M ;
Noël, JP ;
Gomis, JM ;
Appel, M ;
d'Angelo, J ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (01) :121-128
[36]   Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles [J].
Peracchia, MT ;
Vauthier, C ;
Passirani, C ;
Couvreur, P ;
Labarre, D .
LIFE SCIENCES, 1997, 61 (07) :749-761
[37]   Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system [J].
Sahli, H ;
TaponBretaudiere, J ;
Fischer, AM ;
Sternberg, C ;
Spenlehauer, G ;
Verrecchia, T ;
Labarre, D .
BIOMATERIALS, 1997, 18 (04) :281-288
[38]   Typical physicochemical behaviors of chitosan in aqueous solution [J].
Schatz, C ;
Viton, C ;
Delair, T ;
Pichot, C ;
Domard, A .
BIOMACROMOLECULES, 2003, 4 (03) :641-648
[39]   Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect [J].
Son, YJ ;
Jang, JS ;
Cho, YW ;
Chung, H ;
Park, RW ;
Kwon, IC ;
Kim, IS ;
Park, JY ;
Seo, SB ;
Park, CR ;
Jeong, SY .
JOURNAL OF CONTROLLED RELEASE, 2003, 91 (1-2) :135-145
[40]   The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers [J].
Stolnik, S ;
Daudali, B ;
Arien, A ;
Whetstone, J ;
Heald, CR ;
Garnett, MC ;
Davis, SS ;
Illum, L .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1514 (02) :261-279